10133-24-1

Basic information

• Product Name: 7-BROMOMETHYL-BENZO[B]THIOPHENE
• Synonyms: 7-BROMOMETHYL-BENZO[B]THIOPHENE;7-(BROMOMETHYL)-1-BENZOTHIOPHENE;Benzo[b]thiophene,7-(bromomethyl)-
• CAS NO: 10133-24-1
• Molecular Formula: C₉H₇BrS
• Molecular Weight: 227.12088
• Mol File: 10133-24-1.mol
• Article Data: 8

Chemical Properties

• Melting Point: 44 °C
• Boiling Point: 135-137 °C
• Appearance: /
• Density: 1.593±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 7-BROMOMETHYL-BENZO[B]THIOPHENE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-BROMOMETHYL-BENZO[B]THIOPHENE(10133-24-1)
• EPA Substance Registry System: 7-BROMOMETHYL-BENZO[B]THIOPHENE(10133-24-1)

Safety Data

• Hazardous Substances Data: 10133-24-1(Hazardous Substances Data)

Usage

General Description

7-Bromomethyl-benzo[b]thiophene is a chemical compound with the molecular formula C9H7BrS. It is a brominated derivative of benzo[b]thiophene, which is a heterocyclic aromatic compound. The addition of the bromomethyl group to benzo[b]thiophene results in a compound that is widely used as a building block in the synthesis of pharmaceuticals, agrochemicals, and materials. It is known for its versatile reactivity in various chemical reactions, and its valuable applications in organic synthesis. Additionally, 7-bromomethyl-benzo[b]thiophene is also used as a key intermediate in the production of fine chemicals and advanced materials due to its unique structural and electronic properties.

Upstream product

• 14315-15-2 7-methyl-benzo[b]thiophene 
• 34241-39-9 azobisisobutyronitrile 

Downstream Products

• 1079267-22-3 C₁₉H₁₅Cl₂N₃S 
• 1079267-21-2 C₁₉H₁₇N₃S 

Relevant articles and documents

HIV integrase inhibitors

The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS

The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.

Bicyclic heterocycles as HIV integrase inhibitors

The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.